文献速递关节外科

氨甲环酸与全髋及全膝关节置换术后促血栓并发症:一项考虑术者选择偏倚的人群范围安全性分析

Tranexamic Acid and Prothrombotic Complications Following Total Hip and Total Knee Arthroplasty: A Population-Wide Safety Analysis Accounting for Surgeon Selection Bias.
PubMed 文献 · J Arthroplasty · 2022-08-23

该研究基于Premier医疗数据库2008至2020年择期全关节置换患者数据,发现TXA使用率从2008年0.1%升至2020年89.2%;2016至2020年1,120,858例中78.0%接受TXA,接受TXA者促血栓、出血及感染并发症风险均较低,考虑术者选择偏倚后促血栓和出血风险仍较低。

要点

  • 择期全关节置换中TXA使用率从2008年0.1%升至2020年89.2%。
  • 接受TXA者促血栓并发症aOR 0.82(P<.001),出血aOR 0.75(P<.001)。
  • 术者稳定使用TXA(≥90%病例)者促血栓aOR 0.90、出血aOR 0.72。

核心结论

  • 择期全关节置换中广泛使用TXA与促血栓并发症发生率升高无关,考虑术者选择偏倚后该结果仍持续存在。

研究设计与样本

  • 基于Premier医疗数据库的回顾性人群分析,纳入2008至2020年择期全关节置换患者,描述TXA使用趋势。
  • 采用ICD-10编码分析2016至2020年数据,比较接受与未接受TXA患者,并比较术者稳定使用TXA(≥90%病例)与术者不常使用TXA(≤30%病例)的患者。
  • 进行多因素分析和工具变量分析以校正混杂因素,证据等级为III级。

主要发现

  • 2008至2020年TXA使用率从0.1%升至89.2%。
  • 2016至2020年共识别1,120,858例全关节置换(62.1%为全膝关节置换,27.9%为全髋关节置换),其中874,627例(78.0%)接受TXA。
  • 接受TXA者促血栓并发症风险较低(aOR 0.82,P<.001)、出血风险较低(aOR 0.75,P<.001)、感染并发症风险较低(aOR 0.91,P<.001)。
  • 术者稳定使用TXA(≥90%病例)者较术者不常使用TXA(≤30%病例)者促血栓并发症风险较低(aOR 0.90,P<.001)、出血风险较低(aOR 0.72,P<.001)。

关键数值与推荐

  • 接受TXA者促血栓并发症aOR 0.82(P<.001)。
  • 接受TXA者出血并发症aOR 0.75(P<.001)。
  • 接受TXA者感染并发症aOR 0.91(P<.001)。
  • 术者稳定使用TXA(≥90%病例)者促血栓并发症aOR 0.90(P<.001)。
  • 术者稳定使用TXA(≥90%病例)者出血并发症aOR 0.72(P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tranexamic acid (TXA) utilization during total joint arthroplasty (TJA) has become ubiquitous. However, concerns remain regarding the risk of thrombotic complications. The goal of this study was to examine the risk of prothrombotic complications in patients who received TXA during total knee (TKA) and total hip arthroplasty (THA). METHODS: The Premier Healthcare Database was queried for patients who underwent elective TJA. TXA utilization trends were described from 2008 to 2020. Two analyses were performed using ICD-10 codes from 2016 to 2020: (1) patients who received TXA compared to patients who did not receive TXA and, (2) to account for surgeon selection bias, patients whose surgeon utilized TXA consistently (≥90% of cases) compared to patients whose surgeons used TXA infrequently (≤30% of cases). Multivariate and instrumental variable analyses (IVA) were performed to assess outcomes while accounting for confounding factors. TXA utilization increased from 0.1% of cases in 2008 to 89.2% in 2020. From 2016 to 2020, 1,120,858 TJAs were identified (62.1% TKA, 27.9% THA), of which 874,627 (78.0%) received TXA. RESULTS: Patients who received TXA were at lower risk of prothrombotic (adjusted Odds Ratio (aOR) 0.82, P < .001), bleeding (aOR 0.75, P < .001), and infectious complications (aOR 0.91, P < 0.001). Furthermore, patients who underwent surgery from surgeons who utilized TXA consistently were at lower risk for prothrombotic (aOR 0.90, P < .001) and bleeding (aOR 0.72, P < .001) complications. CONCLUSION: The widespread utilization of TXA during elective TJA was not associated with increased rates of prothrombotic complications. These findings persisted after accounting for surgeon selection bias. LEVEL OF EVIDENCE: Level III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Heckmann ND, Haque TF, Piple AS, et al. Tranexamic Acid and Prothrombotic Complications Following Total Hip and Total Knee Arthroplasty: A Population-Wide Safety Analysis Accounting for Surgeon Selection Bias. J Arthroplasty. 2022. PMID: 36007755. doi:10.1016/j.arth.2022.08.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。